Revive (RVVTF) Hits a Snag?
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
First our summary."FDA provided communication that the amended protocol is still under...
Revive Therapeutics (RVVTF) Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company...
What is NAC (N-Acetyl-L-Cysteine)? (Dr Eric Berg)
https://youtu.be/oPdGOrqTfhA
What is NAC good for? (and How Much to Take?)
What is NAC good for?
NAC or N-Acetyl-Cysteine is good for the following:
It helps produce the antioxidant Glutathione...
FDA Issues Final ‘Enforcement Discretion’ Guidance on NAC.
NAC Crosses Major Hurdle With FDA. Is Bucillamine Next.
Josh Long | Aug 01, 2022
"Industry, and especially large online retailers, should now have the level of...
Revive Therapeutics (RVVTF) Enters the Danger Zone.
What Danger You Ask?
Danger #1, the FDA doesn't like the data, and you own the stock.
Danger #2, the FDA does like the data, and...
Revive’s Quarterly Report, Discussion, and a Video!
With 5,000 hospitalizations reported daily (150,000 a month), contracting Covid is not something to be taken lightly - after you get it.
Unless of...
Revive Therapeutics Gains 25% on Positive FDA Comments.
The Company stated yesterday that it "has received positive comments from the FDA in regard to the Company’s request to determine and agree on...
Could Bucillamine be the Key to Preventing Lockdowns in Places Like North Korea?
Revive Therapeutics Nears FDA-EUA Approval or Non-approval, for Bucillamine its Novel Anti-inflammatory and Antioxidant. Bucillamine 'Boosts' Glutathione, a Natural Substance Found in Virtually all...
Revive Therapeutics (RVVTF) Moves a Step Closer to FDA Verdict for Its Novel Covid...
Two Binary Events Directly Ahead.
As in Months Away, not Years. Share Price up 76% During April.
As we stated earlier, Revive Therapeutics (RVVTF)...
Report: First Vaccines, then Antivirals. Will the Anti-Inflammatory Be the Next Success Story in...
New Report on Revive Therapeutics (RVVTF, RVV). Ushering in Advances in Anti-Inflammatory and Antioxidant Drugs, as a Tool Against Covid.
Early Bird Gets the Worm?
Here's...
Latest article
CFO Primer. Tokenize Your Stock?
Had a conversation over Mimosa's Sunday morning with one of our AI Analyst on the tokenization of publicly traded companies, and some interesting information...
Inside the Wild Ride of ATAI (ATAI) $7.22. We’re Up And Out, With a...
Our 6th Billion Dollar Gainer. We're Saying Auf Wiedersehen!
Eli Lilly (LLY) has agreed to pay $6.75 a share in cash upfront ($2.8 billion) –...
AI Meets Mining. MineSignal.AI – Public Inputs – Proprietary Outputs.
MineSignal AI is a technology company that embeds engineers into your business to create and deploy custom AI workflows. It connects directly to your...
